• Using Translational Medicine to Optimize Your Out-licensing Deal
• Biotech-CMO Partnerships – Ways to Create Value
• Critical Issues for Entering the U.S. Market and Partnering with U.S. Companies
• Deal-making in China
• US Patent Law in Flux: Can Dealmakers Adjust?
• Re-invention of the Drug Industry – Case Studies and Their Implications for Future Deal-making

Opening Plenary Session

• Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier Stage Collaborations?
  

• Demonstrating the Value of New Drugs
• Pharma Presentations

• Trends in Early Stage Deal-making
• M&A – The (Hidden) Objective of Every Partnering Deal?
• Creating and Managing Strong Alliances
• What Buyers Want: Understanding What Big Pharma Expects to See in Out-licensing Documents

• Financing Companies / Building Companies – Two Sides of the Same Coin or Different Currencies?
• Deal-making with Japanese Companies
• Biomarkers – Alive with Opportunities for Partnering
• Transformative Trends in Oncology

Keynote Plenary Discussion

• A Day in the Life of Experienced Dealmakers